Skip to main content

lacosamide (Vimpat®)

 

Status: In progress

Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in children from 2 years of age to ≤  4 years of age with epilepsy.

Medicine details

Medicine name lacosamide (Vimpat®)
Formulation 10 mg/ml syrup; 10 mg/ml solution for infusion; 50 mg, 100 mg, 150 mg, 200 mg film-coated tablets
Reference number 4698
Indication

As above

Company UCB Pharma Ltd
BNF chapter Central nervous system
Submission type Licence extension for paediatric use
Status In progress
AWMSG meeting date 14/09/2022
Date of issue TBC
Follow AWTTC: